191 related articles for article (PubMed ID: 28056411)
21. Measuring ovarian function in young cancer survivors.
Su HI
Minerva Endocrinol; 2010 Dec; 35(4):259-70. PubMed ID: 21178920
[TBL] [Abstract][Full Text] [Related]
22. Ovarian function following radiation and chemotherapy for cancer.
Lo Presti A; Ruvolo G; Gancitano RA; Cittadini E
Eur J Obstet Gynecol Reprod Biol; 2004 Apr; 113 Suppl 1():S33-40. PubMed ID: 15041128
[TBL] [Abstract][Full Text] [Related]
23. Anti-Müllerian Hormone in Female Adolescent Cancer Patients Before, During, and After Completion of Therapy: A Pilot Feasibility Study.
Gupta AA; Lee Chong A; Deveault C; Traubici J; Maloney AM; Knight S; Lorenzo A; Allen L
J Pediatr Adolesc Gynecol; 2016 Dec; 29(6):599-603. PubMed ID: 27184535
[TBL] [Abstract][Full Text] [Related]
24. Immunosuppressive and cytotoxic chemotherapy: long-term complications.
Schein PS; Winokur SH
Ann Intern Med; 1975 Jan; 82(1):84-95. PubMed ID: 67817
[TBL] [Abstract][Full Text] [Related]
25. Second Cancer Risk Up to 40 Years after Treatment for Hodgkin's Lymphoma.
Schaapveld M; Aleman BM; van Eggermond AM; Janus CP; Krol AD; van der Maazen RW; Roesink J; Raemaekers JM; de Boer JP; Zijlstra JM; van Imhoff GW; Petersen EJ; Poortmans PM; Beijert M; Lybeert ML; Mulder I; Visser O; Louwman MW; Krul IM; Lugtenburg PJ; van Leeuwen FE
N Engl J Med; 2015 Dec; 373(26):2499-511. PubMed ID: 26699166
[TBL] [Abstract][Full Text] [Related]
26. Health-related quality of life in early breast cancer.
Groenvold M
Dan Med Bull; 2010 Sep; 57(9):B4184. PubMed ID: 20816024
[TBL] [Abstract][Full Text] [Related]
27. Low Anti-Müllerian Hormone in Pediatric Cancer Survivors in the Early Years after Gonadotoxic Therapy.
Elchuri SV; Patterson BC; Brown M; Bedient C; Record E; Wasilewski-Masker K; Mertens AC; Meacham LR
J Pediatr Adolesc Gynecol; 2016 Aug; 29(4):393-9. PubMed ID: 26924632
[TBL] [Abstract][Full Text] [Related]
28. Dose-Effect Relationship of Alkylating Agents on Testicular Function in Male Survivors of Childhood Lymphoma.
Servitzoglou M; De Vathaire F; Oberlin O; Patte C; Thomas-Teinturier C
Pediatr Hematol Oncol; 2015; 32(8):613-23. PubMed ID: 26561347
[TBL] [Abstract][Full Text] [Related]
29. Long-term endocrine side effects of childhood Hodgkin's lymphoma treatment: a review.
van Dorp W; van Beek RD; Laven JS; Pieters R; de Muinck Keizer-Schrama SM; van den Heuvel-Eibrink MM
Hum Reprod Update; 2012; 18(1):12-28. PubMed ID: 21896559
[TBL] [Abstract][Full Text] [Related]
30. A 10-year follow up of reproductive function in women treated for childhood cancer.
Nielsen SN; Andersen AN; Schmidt KT; Rechnitzer C; Schmiegelow K; Bentzen JG; Larsen EC
Reprod Biomed Online; 2013 Aug; 27(2):192-200. PubMed ID: 23768622
[TBL] [Abstract][Full Text] [Related]
31. [Premature ovarian failure after chemotherapy for breast cancer].
Mathelin C; Brettes JP; Diemunsch P
Bull Cancer; 2008 Apr; 95(4):403-12. PubMed ID: 18495569
[TBL] [Abstract][Full Text] [Related]
32. Fertility and menopausal outcomes in young breast cancer survivors.
Partridge AH; Gelber S; Peppercorn J; Ginsburg E; Sampson E; Rosenberg R; Przypyszny M; Winer EP
Clin Breast Cancer; 2008 Feb; 8(1):65-9. PubMed ID: 18501060
[TBL] [Abstract][Full Text] [Related]
33. Gonadotropin-Releasing Hormone Agonists for Ovarian Function Preservation in Premenopausal Women Undergoing Chemotherapy for Early-Stage Breast Cancer: A Systematic Review and Meta-analysis.
Munhoz RR; Pereira AA; Sasse AD; Hoff PM; Traina TA; Hudis CA; Marques RJ
JAMA Oncol; 2016 Jan; 2(1):65-73. PubMed ID: 26426573
[TBL] [Abstract][Full Text] [Related]
34. Secondary Breast Cancer Risk by Radiation Volume in Women With Hodgkin Lymphoma.
Conway JL; Connors JM; Tyldesley S; Savage KJ; Campbell BA; Zheng YY; Hamm J; Pickles T
Int J Radiat Oncol Biol Phys; 2017 Jan; 97(1):35-41. PubMed ID: 27979454
[TBL] [Abstract][Full Text] [Related]
35. Ovarian function in female survivors after multimodal Ewing sarcoma therapy.
Raciborska A; Bilska K; Filipp E; Drabko K; Rogowska E; Chaber R; Pogorzała M; Połczyńska K; Adrianowska N; Rodriguez-Galindo C; Maciejewski T
Pediatr Blood Cancer; 2015 Feb; 62(2):341-345. PubMed ID: 25399867
[TBL] [Abstract][Full Text] [Related]
36. Normal ovarian function and assessment of ovarian reserve in the survivor of childhood cancer.
Johnston RJ; Wallace WH
Pediatr Blood Cancer; 2009 Aug; 53(2):296-302. PubMed ID: 19514070
[TBL] [Abstract][Full Text] [Related]
37. Undetectable antimüllerian hormone levels and recovery of chemotherapy-induced ovarian failure in women with breast cancer on an oral aromatase inhibitor.
Dieudonné AS; Vandenberghe J; Geerts I; Billen J; Paridaens R; Wildiers H; Neven P
Menopause; 2011 Jul; 18(7):821-4. PubMed ID: 21326118
[TBL] [Abstract][Full Text] [Related]
38. Reproductive status in adult male long-term survivors of childhood cancer.
Tromp K; Claessens JJ; Knijnenburg SL; van der Pal HJ; van Leeuwen FE; Caron HN; Beerendonk CC; Kremer LC
Hum Reprod; 2011 Jul; 26(7):1775-83. PubMed ID: 21489977
[TBL] [Abstract][Full Text] [Related]
39. Amenorrhea following chemotherapy for breast cancer: effect on disease-free survival.
Collichio F; Pandya K
Oncology (Williston Park); 1994 Dec; 8(12):45-52. PubMed ID: 7888312
[TBL] [Abstract][Full Text] [Related]
40. Assessment of ovarian failure and osteoporosis in premenopausal breast cancer survivors.
McCune JS; Games DM; Espirito JL
J Oncol Pharm Pract; 2005 Jun; 11(2):37-43. PubMed ID: 16460603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
